Lucy Shapiro, Director at Anacor Pharmaceuticals Inc (ANAC), sold 30,000 shares at $6.66 ($200K) on 2012-10-05, disclosed to the SEC on 2012-10-05.
Scheduled sale ($200k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.69 | 15,000 | $100K | 50.1% |
| 2 | $6.66 | 15,000 | $100K | 49.9% |
| Total | $6.67 avg | 30,000 | $200K | 100% |
| Filing → |
| ANAC | SELL | 2014-03-25 | $1.7M | — | Filing → |
| ANAC | SELL | 2013-04-19 | $200K | — | Filing → |
| ANAC | SELL | 2013-03-22 | $138K | — | Filing → |